Inhibition of prostate cancer cell growth by 3′,4′,5′-trimethoxyflavonol (TMFol)

Cancer Chemotherapy and Pharmacology

Volumn 76, Issue 1, 2015, Pages 179-185

  Hill, C U F Kelly ^a   Saad, Shaban E A ^a   Britton, Robert G ^a   Gescher, Andreas J ^a   Sale, Stewart ^a   Brown, Karen ^a   Howells, Lynne M ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

3 4 5 Trimethoxyflavonol; Apoptosis; Prostate cancer management

Indexed keywords

3',4',5 TRIMETHOXYFLAVONOL; ANTINEOPLASTIC AGENT; FISETIN; FLAVONOL DERIVATIVE; QUERCETIN; UNCLASSIFIED DRUG; 3',4',5'-TRIMETHOXYFLAVONOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE M PHASE; CELL FRACTIONATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER CELL LINE; TUMOR CELL INOCULATION; TUMOR VOLUME; ANIMAL; CELL PROLIFERATION; DRUG EFFECTS; DRUG SCREENING; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; PROSTATIC NEOPLASMS; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLAVONOLS; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; PROSTATIC NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84934441810     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-015-2771-2     Document Type: Article

References (13)

1. Syed DN, Khan N, Afaq F, Mukhtar H (2007) Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol Biomark Prev 16:2193-2203
2. Khan N, Asim M, Afaq F, Abu Zaid M, Mukhtar H (2008) A novel dietary flavonoid fisetin inhibits androgen receptor signaling and tumor growth in athymic nude mice. Cancer Res 68:8555-8563
3. Haddad AQ, Fleshner N, Nelson C, Saour B, Musquera M, Venkateswaran V, Klotz L (2010) Antiproliferative mechanisms of the flavonoids 2,2′-dihydroxychalcone and fisetin in human prostate cancer cells. Nutr Cancer 62:668-681
4. Sak K (2014) Site-specific anticancer effects of dietary flavonoid quercetin. Nutr Cancer 66:177-193
5. Aalinkeel R, Bindukumar B, Reynolds JL, Sykes DE, Mahajan SD, Chadha KC, Schwartz SA (2008) The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90. Prostate 68:1773-1789
6. Britton RG, Fong I, Saad S, Brown K, Steward WP, Gescher A, Sale S (2009) Synthesis of the flavonoid 3′,4′,5′-trimethoxyflavonol and its determination in plasma and tissues of mice by HPLC with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 877:939-942
7. Howells LM, Britton RG, Mazzoletti M, Greaves P, Broggini M, Brown K, Steward WP, Gescher AJ, Sale S (2010) Preclinical colorectal cancer chemopreventive efficacy and p53-modulating activity of 3′,4′,5′-trimethoxyflavonol, a quercetin analogue. Cancer Prev Res (Phila) 3:929-939
8. Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DA, Glennie MJ, Kelland LR, Robinson V, Stratford IJ, Tozer GM, Watson S, Wedge SR, Eccles SA, Committee of the National Cancer Research I (2010) Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102:1555-1577
9. Tomayko MM, Reynolds CP (1989) Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24:148-154
10. Britton RG, Horner-Glister E, Pomenya OA, Smith EE, Denton R, Jenkins PR, Steward WP, Brown K, Gescher A, Sale S (2012) Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents. Eur J Med Chem 54:952-958
11. Halliwell B, Clement MV, Ramalingam J, Long LH (2000) Hydrogen peroxide. Ubiquitous in cell culture and in vivo? IUBMB Life 50:251-257
12. Saad SE, Jones DJ, Norris LM, Horner-Glister E, Patel KR, Britton RG, Steward WP, Gescher AJ, Brown K, Sale S (2012) Tissue distribution and metabolism of the putative cancer chemopreventive agent 3′,4′,5′-trimethoxyflavonol (TMFol) in mice. Biomed Chromatogr 26:1559-1566
13. Frost P, Moatamed F, Hoang B, Shi Y, Gera J, Yan H, Frost P, Gibbons J, Lichtenstein A (2004) In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model. Blood 104:4181-4187